Ledger.Open graph →
SEC Form D · Amendment · filed September 4, 2020

Ethicann Pharmaceuticals Inc

Offering
$1.0M
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TORONTO, Ontario, Canada
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Ulrich D. Elben · Ontario, Ontario, CanadaExecRobert D. Auritt · Ontario, Ontario, CanadaExec · Director · PromoterBrandon F. Price · Ontario, Ontario, CanadaExec · Director · PromoterDwayne L. Lashyn · Ontario, Ontario, CanadaDirectorNeil D. Maruoka · Ontario, Ontario, CanadaDirectorBruce F. Mackler · Ontario, Ontario, CanadaExec · Director · PromoterSuresh Kavan · Knoxville, TNExec · Director · PromoterPhillip Sharp · San Francisco, CAExec · Director · PromoterAdam Balinsky · Stamford, CTExec · Director · PromoterAnthony Arnold · New York, NYDirectorLisa Stinnett · Knoxville, TNExecScott Rose · Stamford, CTDirectorJames J. Paglia · Lantana, TXExec · Director · PromoterSherree J. Tipton · Michigan City, INExec · Director · PromoterJohn J. Stimley · Michigan City, INDirectorDouglas G. Bergeron · New York, NYExec · Director · PromoterPaul N. Vogel · Culver City, CADirectorUlin N. Vijaya · Culver City, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗